跳至主要内容
临床试验/IRCT20120520009801N6
IRCT20120520009801N6尚未招募3 期

The effect of dextromethorphan on the severity of symptoms in patients with obsessive-compulsive disorder: A double blinded, randomized clinical trial

Mashhad University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • OCD patients who have been treated with high doses of SSRI for at least 8 weeks but have a Y-BOCS index score higher than 15. (High doses of SSRI includ: Sertraline 200mg/day, Paroxetine 60mg/day, Fluoxetine 80mg/day and Fluvoxamine mg/day)
  • subjects aged 18 to 60 years
  • Obtaining the patient's informed consent

排除标准

  • Pregnancy or breastfeeding
  • Using serotonergic drugs other than SSRIs
  • Use of NMDA receptor antagonists other than dextromethorphan and memantine
  • Psychotic and bipolar disorders (based on DSM-5 criteria)
  • Liver dysfunction (LFT> 3ULN)
  • Kidney dysfunction (GFR <60 ml / kg / min)
  • Thyroid Disorders (Based on Thyroid Function Test)
  • History of seizures

研究者

相似试验

The effect of dextromethorphan on the severity of... | 临床试验